SEC CIK 1555508
Balachandran Madhavan
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| AMGNview stock → | 55,996 | 2016-05-04 |
| QUREview stock → | 43,254 | 2026-06-17 |
Position History — QURE
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — QURE
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-06-17 | Option exercise (derivative) | 5,295 | $0.00 | 0 |
| 2026-06-17 | Open-market sale | 1,690 | $42.60 | 43,254 |
| 2026-06-17 | Open-market sale | 4,700 | $43.66 | 44,944 |
| 2026-06-17 | Open-market sale | 5,295 | $47.08 | 49,644 |
| 2026-06-17 | Option exercise | 6,390 | $19.39 | 54,939 |
| 2026-06-17 | Option exercise | 5,295 | $31.71 | 48,549 |
| 2026-06-15 | Option exercise (derivative) | 10,000 | $0.00 | 0 |
| 2026-06-15 | Open-market sale | 10,000 | $27.85 | 43,254 |
| 2026-06-15 | Option exercise | 10,000 | $8.49 | 53,254 |
| 2026-06-11 | Open-market sale | 1,993 | $27.06 | 43,254 |
| 2026-06-10 | Grant / award (derivative) | 13,980 | $0.00 | 13,980 |
| 2026-06-10 | Grant / award | 7,550 | $0.00 | 45,247 |
| 2025-06-20 | Open-market sale | 2,112 | $14.45 | 37,697 |
| 2025-06-11 | Grant / award (derivative) | 15,630 | $0.00 | 15,630 |
| 2025-06-11 | Grant / award | 7,970 | $0.00 | 39,809 |
| 2024-06-19 | Grant / award (derivative) | 15,840 | $0.00 | 15,840 |
| 2024-06-19 | Grant / award | 8,080 | $0.00 | 31,839 |
| 2024-06-13 | Open-market sale | 2,231 | $5.12 | 23,759 |
| 2023-06-16 | Open-market sale | 2,283 | $18.91 | 25,990 |
| 2023-06-13 | Grant / award (derivative) | 17,060 | $0.00 | 17,060 |
| 2023-06-13 | Grant / award | 8,700 | $0.00 | 28,273 |
| 2023-02-27 | Open-market sale | 384 | $19.99 | 19,573 |
| 2022-06-15 | Grant / award (derivative) | 17,810 | $0.00 | 17,810 |
| 2022-06-15 | Grant / award | 9,080 | $0.00 | 19,957 |
| 2022-02-28 | Open-market sale | 602 | $16.70 | 10,877 |
| 2022-02-24 | Grant / award (derivative) | 2,645 | $0.00 | 2,645 |
| 2022-02-24 | Grant / award | 1,534 | $0.00 | 11,479 |
| 2021-03-02 | Open-market sale | 505 | $37.50 | 9,945 |
| 2021-02-25 | Grant / award (derivative) | 4,107 | $0.00 | 4,107 |
| 2021-02-25 | Grant / award | 2,382 | $0.00 | 10,450 |
| 2020-02-27 | Grant / award (derivative) | 3,620 | $0.00 | 3,620 |
| 2020-02-27 | Grant / award | 2,063 | $0.00 | 8,068 |
| 2020-01-28 | Open-market sale | 807 | $62.20 | 6,005 |
| 2019-01-28 | Open-market sale | 1,210 | $31.31 | 6,812 |
| 2019-01-25 | Grant / award (derivative) | 5,295 | $0.00 | 5,295 |
| 2019-01-25 | Grant / award | 3,230 | $0.00 | 8,022 |
| 2018-01-26 | Grant / award (derivative) | 6,390 | $0.00 | 6,390 |
| 2018-01-26 | Grant / award | 4,792 | $0.00 | 4,792 |
| 2017-09-20 | Grant / award (derivative) | 10,000 | $0.00 | 10,000 |
| 2017-09-14 | — | — | — | 0 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.